Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?-Reference-Cited by-同舟云学术

Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?

Published:2016-12 Issue:5 Volume:96 Page:951-958
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Abou Yehia Zeinab,Mikhaeel George N.,Smith Grace,Pinnix Chelsea C.,Milgrom Sarah A.,Tang Chad,Jiang Wen^ORCID,Fanale Michelle A.,Oki Yasuhiro,Shank JoAnn H.,Horace Trisha,Reddy Jay,Akhtari Mani,Gunther Jillian R.,Suki Tina,Allen Pamela K.,Turner Shryll,Mawlawi Osama,Dabaja Bouthaina S.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial;Engert;J Clin Oncol,2007

2. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma;Engert;N Engl J Med,2010

3. Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: A systematic review;Herbst;Haematologica,2010

4. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial;Eich;J Clin Oncol,2010

5. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 Years of follow-up of the GHSG HD9 study;Engert;J Clin Oncol,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy – interventional radiotherapy;Journal of Contemporary Brachytherapy;2022

2. Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration;International Journal of Radiation Oncology*Biology*Physics;2021-01

3. Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016;Journal of Clinical Oncology;2020-12-10

4. Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?;eJHaem;2020-02-07

5. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease;Radiation Oncology;2019-09-02